Company intelligence
Valtera Group Ltd
Exceptional People. Extraordinary Impact
About Valtera Group Ltd
Valtera partners with life sciences and applied technology companies at critical stages of growth. We deliver permanent and contract talent, introduce growth capital, and support strategic asset opportunities across Biotech, Pharma, and MedTech. Our work connects the right people, funding, and assets to help innovative companies move faster, scale smarter, and execute with confidence. Built for growth. Designed for impact.
Verified activity
Signals from Valtera Group Ltd
8 published signals
Presence & Recognition
Valtera Group Ltd played up to Aberdeen to play Trump International Golf Links on Monday and Tuesday.
Reported by Tom Moore
Presence & Recognition
Valtera Group Ltd played Friday, Edgbaston for day two of England v Pakistan.
Reported by Tom Moore
Presence & Recognition
Valtera Group Ltd met multiple stakeholders on a multi-campaign leadership project in Dublin this morning.
Reported by Tom Moore
Presence & Recognition
Valtera Group Ltd filmed a morning content for CPHI to come.
Reported by Tom Moore
Presence & Recognition
Valtera Group Ltd boys are back at nursery.
Reported by Tom Moore
Operations & Supply
Valtera Group Ltd roadtripped with Sam and Fleur to Galway to see five contractors, qualify a few more roles, two permanent hires, and a three-headcount engineering project.
Reported by Tom Moore
Operations & Supply
Valtera Group Ltd has flown out of the blocks for the first full week of September, Q3 closing out, and the company could double its best-ever month if the month lands the way it's shaping up.
Reported by Tom Moore
Customers & Market
Valtera Group Ltd noted that Roche spent $1.5bn on a drug that is still preclinical, with the upfront alone being $75m and the full deal running to $1.53bn.
Reported by Tom Moore